The Mix: UAB Expert Speaks at Neuroscience 2012 of experimental drug therapies for Parkinson's disease

Patients with Parkinson's die at twice the rate of those without the disease.

For these reasons, researchers have been urgently seeking for years to understand Parkinson's to the point where they can begin to design drugs that go beyond symptom relief to counter the inflammation and nerve cell death at the disease's root. Read More...